Alpine Associates Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Alpine Associates Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-521,900	Closed	-$31.3M	–	74
2021 Q1	$31.3M	Buy	+521,900	New	+$18.9M	0.85%	32

Alpine Associates Management's PAND Position: Q2 2021 in Review

Alpine Associates Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 521,900 shares — an estimated $31.3M sold.

Alpine Associates Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $31.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Alpine Associates Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Alpine Associates Management sold 521,900 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $31.3M.
Alpine Associates Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Alpine Associates Management's Pandion Therapeutics Inc. Common Stock position peaked at $31.3M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Alpine Associates Management's 13F filing for Q2 2021, filed 11 Aug 2021.